Table 1.
Plasmid; Promoter | Expression Strain | Growth condition; Inducer | Induction Temp.; Time; Yield | Ref. |
---|---|---|---|---|
AAT expression and purification from soluble cell lysate | ||||
pOTSα (with N-term deleted AAT); λPL | AR120 | 32 °C; Thermal induction at A650 of 1.0 |
42 °C; 60–90 m; NR |
[9] |
λPL | TGE7213 | 15 1 culture at 30 °C; Thermal induction at A600 of 10 |
42 °C; 6 h; NR | [10] |
pTermat; T7 | BL21(DE3) | 101 medium 37 °Ca; IPTG (0.1% w/v) at A600 of 10; Rifampicin at 0.1 mg/ml after 30 min of induction |
37 °C; 3.5 h; 0.8 mg/g wet cell paste |
[11] |
pEAT8 (M2 AAT); T7 | BL21(DE3) | Semi-defined medium; 0.4 mM IPTG at A600 of 1.4 |
37 °C; 3 h; NR | [12] |
pMAL-C2x (MBP-AAT); pTac | BL21CPb | 0.3 mM IPTG at A600 of 0.5b | 37 °C; 8 h; 7–9 mg/l |
[13] |
a. pQE31 (His6-AAT); T5 b. pQE30 (His6-AAT); T5 |
SG13009 (pREP4) |
2xYT medium; a. 1.0 mM IPTG at A600 of 0.8–1 b. 0.5 – 1.0 mM IPTG at A600 of 0.5 – 0.7 |
a. 30 °C; 3 h;NR b. 37 °C; 4 h;NR |
[14] [15] |
pEAT8–137 (M2 AAT); T7 | BL21(DE3) | 37 ° C, LB medium; 0.4 mM IPTG at A600 of 0.7–0.8 |
30 °C; 5 h; 6–7 mg/1 |
[16]c |
| ||||
AAT expression and purification from inclusion bodies | ||||
pαBcl (N-terminal deleted AAT); λPL | AR120 | 32 °C until A650 of 1.0; Thermal induction |
42 °C; 60–90 m; NR |
[9] |
pEAT8 (M2 AAT); T7 | BL21(DE3) | M9ZB medium; 0.4 mM IPTG at A600 of 0.8 |
40 °C; 3 h;NR |
[17] |
pTermat (Chimeric- AAT); T7 | BL21(DE3) | 37 °C; IPTG (0.1% w/v) at A600 of 10; Rifampicin at 0.1 mg/ml after 30 m of induction |
37 °C; 3.5 h; 10–15 mg/1 |
[18] |
pQE30(His6-Multi9AAT); T5 | SG-13009 | M9 Minimal medium; 1 mM IPTG at A600 of 0.5 |
4.5 h; NR | [19] |
pTermat; T7 | BL21(DE3) | 2xYT medium; 0.5–1.0 mM IPTG at A600 of 0.5–0.7; Rifampicin at 0.05 mg/ml after 30 m of induction | 37 °C; 4 h; NR | [15] |
Defined medium for fermentation
Optimized strain and growth condition from [13]
Current Study
NR not reported